1. Acknowledgement to Referees

   Acknowledgement to Referees 10 November 2018 Pages: 527 - 530

2. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?

   • Ali Berkant Avci
   • Eugen Feist
   • Gerd Rüdiger Burmester

   Leading Article 29 November 2018 Pages: 531 - 546

   

3. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier

   • Danica B. Stanimirovic
   • Jagdeep K. Sandhu
   • Will J. Costain

   Leading Article Open access 10 October 2018 Pages: 547 - 559

   

4. Bispecific Antibody Emicizumab for Haemophilia A: A Breakthrough for Patients with Inhibitors

   • Johnny N. Mahlangu

   Leading Article 14 November 2018 Pages: 561 - 570

   

5. Recombinant Antibody Production in CHO and NS0 Cells: Differences and Similarities

   • Venkata Gayatri Dhara
   • Harnish Mukesh Naik
   • Michael J. Betenbaugh

   Review Article 30 November 2018 Pages: 571 - 584

   

6. Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

   • Wânia Cristina da Silva
   • Vânia Eloisa de Araujo
   • Eli Iola Gurgel Andrade

   Systematic Review Open access 30 November 2018 Pages: 585 - 606

   

7. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study

   • Cristina Scavone
   • Maurizio Sessa
   • Annalisa Capuano

   Original Research Article Open access 20 October 2018 Pages: 607 - 617

   

8. In-Use Physicochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion

   • Su Jung Kim
   • Joon Won Lee
   • Ji Young Kim

   Short Communication 02 November 2018 Pages: 619 - 625

9. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn’s Disease

   • Lesley J. Scott

   Adis Drug Evaluation 08 October 2018 Pages: 627 - 634

   

10. GP2017: An Adalimumab Biosimilar

    • Young-A Heo

    Adis Biosimilar Brief 20 November 2018 Pages: 635 - 638

    

11. PF-06438179/GP1111: An Infliximab Biosimilar

    • Zaina T. Al-Salama

    Adis Biosimilar Brief Open access 04 October 2018 Pages: 639 - 642

    

12. Correction to: PF-06438179/GP1111: An Infliximab Biosimilar

    • Zaina T. Al-Salama

    Correction Open access 15 November 2018 Pages: 643 - 643